SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-077725
Filing Date
2008-12-22
Accepted
2008-12-22 08:01:45
Documents
12
Period of Report
2008-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-30911_18k.htm 8-K 27695
2 EX-99.1 a08-30911_1ex99d1.htm EX-99.1 34545
3 EX-99.2 a08-30911_1ex99d2.htm EX-99.2 17230
4 GRAPHIC g309111moi001.gif GRAPHIC 109460
5 GRAPHIC g309111moi002.gif GRAPHIC 187297
6 GRAPHIC g309111moi003.gif GRAPHIC 91673
7 GRAPHIC g309111moi004.gif GRAPHIC 90471
8 GRAPHIC g309111moi005.gif GRAPHIC 77774
9 GRAPHIC g309111moi006.gif GRAPHIC 92164
10 GRAPHIC g309111moi007.gif GRAPHIC 61885
11 GRAPHIC g309111moi008.gif GRAPHIC 78358
12 GRAPHIC g309111moi009.gif GRAPHIC 89400
  Complete submission text file 0001104659-08-077725.txt   1292760
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 081262619
SIC: 2834 Pharmaceutical Preparations